Skip to content
Disclosery

EXANE DERIVATIVES: ASML position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ASML, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,521 ASML shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,521 shares
    Change vs previous 13F -880 shares

    0.69% of the 13F portfolio, value $1,199,454.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,401 shares
    Change vs previous 13F -34 shares

    0.64% of the 13F portfolio, value $2,271,498.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,435 shares
    Change vs previous 13F +2,258 shares

    0.67% of the 13F portfolio, value $2,734,652.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,177 shares
    Change vs previous 13F +594 shares

    0.22% of the 13F portfolio, value $876,969.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 583 shares
    Change vs previous 13F not available

    0.1% of the 13F portfolio, value $411,835.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).